Farms.com Home   News

What to do when crop prices are volatile

"The crop growing period of market action is sometimes referred to as the ‘silly season’,” says Neil Blue, provincial crops market analyst with the Alberta government. “Dryness in both the Canadian Prairies and U.S. corn/soybean belt plus intensified Russian attacks on Ukraine grain export structures have caused a crop market price rally. Adding in the influences of the speculative trade results in an extremely volatile market. What can a producer do in this situation?"

First, Blue says producers should review their cash flow situation at least 2 or 3 months forward. What farm and personal expenses and what loans will require payments? What amounts from sources of cash inflow, be it product sales, other income, or loans will be available?

"The federal Advance Payments Program (APP) is a loan source to consider for cash flow needs,” says Blue. “Using farm commodities as security, the APP can potentially provide up to $1 million as an advance, with the first $350,000 of the advance interest free during this year. With a current chartered bank prime interest rate of 7.2%, the interest savings of accessing the APP advance can be significant."

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.